Essential Access Health
CAGE Code: 335K4
NCAGE Code: 335K4
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 074121492
Summary
Essential Access Health is an Active Commercial Supplier with the Cage Code 335K4 and is tracked by Dun & Bradstreet under DUNS Number 074121492..
Address
3600 Wilshire Blvd Ste 600
Los Angeles CA 90010-2610
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Simco Sales, Inc. G I Maintenance Los Angeles Potato Distributors Inc Pacific Radio Electronics Computer Graphics & Networking, Inc. Lehigh Safety Shoe Co Calumet Photographic Inc General Photo-Grapic Inc Fairchild Aviation Recorders Data Grimes-Stassforth Stationary Co Tork-Master Div Of General Controls Victory Salvage Inc. Abbott Instrument And Engineering Co Ells Dick Co Fiedler C O Cc Security Systems University Of California National Sam Sung Air Control Llc Electronic Stationers Gentle Touch House Keeping Llc
Frequently Asked Questions (FAQ) for CAGE 335K4
- What is CAGE Code 335K4?
- 335K4 is the unique identifier used by NATO Organizations to reference the physical entity known as Essential Access Health located at 3600 Wilshire Blvd Ste 600, Los Angeles CA 90010-2610, United States.
- Who is CAGE Code 335K4?
- 335K4 refers to Essential Access Health located at 3600 Wilshire Blvd Ste 600, Los Angeles CA 90010-2610, United States.
- Where is CAGE Code 335K4 Located?
- CAGE Code 335K4 is located in Los Angeles, CA, USA.
Contracting History for CAGE 335K4 Most Recent 25 Records
- 75N94023F00001
- Ovaprene Phase 1: Protocol Finalization, Regulatory Approval, Start-Up, And Commencement Of Recruitment, Screening, And Enrollment For The Ovaprene Vaginal Device Clinical Trial
- 26 Sep 2023
- Ovaprene Phase 1: Protocol Finalization, Regulatory Approval, Start-Up, And Commencement Of Recruitment, Screening, And Enrollment For The Ovaprene Vaginal Device Clinical Trial
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $349,327.00
- Department Of Health And Human Services (Hhs)
- 75N94020D00015
- Eo 14042-To Conduct Phase I, Ii, Iii Or Iv Contraceptive Trials In Women, Treatment Trials Of Gynecologic Conditions Such As Endometriosis Or Leiomyomata, And Development Of Research Protocols On A Task Order Basis Under A Seven (7) Year Indefinite-D
- 22 Dec 2022
- Eo 14042-To Conduct Phase I, Ii, Iii Or Iv Contraceptive Trials In Women, Treatment Trials Of Gynecologic Conditions Such As Endometriosis Or Leiomyomata, And Development Of Research Protocols On A Task Order Basis Under A Seven (7) Year Indefinite-D
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N94020D00015
- To Conduct Phase I, Ii, Iii Or Iv Contraceptive Trials In Women, Treatment Trials Of Gynecologic Conditions Such As Endometriosis Or Leiomyomata, And Development Of Research Protocols On A Task Order Basis Under A Seven (7) Year Indefinite-Delivery,
- 30 Jul 2021
- To Conduct Phase I, Ii, Iii Or Iv Contraceptive Trials In Women, Treatment Trials Of Gynecologic Conditions Such As Endometriosis Or Leiomyomata, And Development Of Research Protocols On A Task Order Basis Under A Seven (7) Year Indefinite-Delivery,
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- 75N94020F00001
- Core Function Activities
- 19 Jul 2022
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $19,213.00
- Department Of Health And Human Services (Hhs)
- 75N94020F00001
- Core Function Activities
- 13 Jul 2023
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $42,118.00
- Department Of Health And Human Services (Hhs)
- HHSN27500001
- Core Function Activities
- 27 Jun 2022
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $159,238.68
- Department Of Health And Human Services (Hhs)
- HHSN27500003
- Clinical Evaluation Of Novel Products For Female Contraception, Main Study
- 30 Dec 2021
- Clinical Evaluation Of Novel Products For Female Contraception, Main Study
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $743,362.00
- Department Of Health And Human Services (Hhs)
- HHSN27500003
- Clinical Evaluation Of Novel Products For Female Contraception, Main Study
- 28 Sep 2021
- Clinical Evaluation Of Novel Products For Female Contraception, Main Study
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $743,362.00
- Department Of Health And Human Services (Hhs)
- HHSN275201300022I
- Contraceptive Clinical Trial Network - Female Sites
- 22 Dec 2022
- Contraceptive Clinical Trial Network - Female Sites
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $0.00
- Department Of Health And Human Services (Hhs)
- HHSN27500001
- Core Function Activities
- 1 Jun 2023
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $151,384.10
- Department Of Health And Human Services (Hhs)
- 75N94020F00001
- Core Function Activities
- 30 Jul 2021
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $15,677.00
- Department Of Health And Human Services (Hhs)
- 75N94020F00001
- Core Function Activities
- 18 Aug 2023
- Core Function Activities
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $42,118.00
- Department Of Health And Human Services (Hhs)
- HHSN27500002
- A Multi-Center, Randomized Study To Evaluate The Pharmacokinetic And Pharmacodynamic Profile, Contraceptive Efficacy And Safety Of Daily Oral Low Dose Ulipristal Acetate
- 30 Dec 2021
- A Multi-Center, Randomized Study To Evaluate The Pharmacokinetic And Pharmacodynamic Profile, Contraceptive Efficacy And Safety Of Daily Oral Low Dose Ulipristal Acetate
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $1,425,674.00
- Department Of Health And Human Services (Hhs)